Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale By: Philadelphia Business Journal via Business Journals August 12, 2022 at 11:42 AM EDT A Philadelphia biotechnology company gets orphan drug status for its new drug candidate. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
